Cladribine (Compound)

Synonyms:Cladribine, 2-Chloro-2'-deoxyadenosine, 4291-63-8, Leustatin, 2-Chlorodeoxyadenosine, 2-CdA, Chlorodeoxyadenosine, CldAdo, ADENOSINE, 2-CHLORO-2'-DEOXY-, Litak, 2-Chloro-2'-deoxy-beta-adenosine, Cladaribine, RWJ 26251, 2-chloro-deoxyadenosine, 2ClAdo, UNII-47M74X9YT5, MLS000028377, 2CdA, Cladarabine, RWJ-26251, (2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol, Leustat, SMR000058553, (2R,3S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol, (2R,3S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol, 2-chloro-6-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine, CHEBI:567361, 47M74X9YT5, MFCD00153939, NSC-105014, Movectro, Mylinax, DSSTox_CID_2828, DSSTox_RID_76747, DSSTox_GSID_22828, cladribina, cladribinum, mavenclad, Leustatin (TN), CL9, CAS-4291-63-8, 2 Chlorodeoxyadenosine, SR-01000003063, NSC 105014, BRN 0624220, Cladiribine, CCRIS 9374, Adenosine, 2-chloro-2'-deoxy, HSDB 7564, 2-Chloro-6-amino-9-(2-deoxy-beta-D-erythropentofuranosyl)purine, Cladribine [USAN:USP:INN:BAN], Mavenclad (TN), NCGC00018167-03, Cladribine- Bio-X, S1199, RWJ-26251-000, Opera_ID_1191, SCHEMBL3775, CHEMBL1619, Cladribine (JAN/USP/INN), 2-chloro-2'-deoxy-adenosine, cid_20279, MLS000028484, MLS000759397, MLS001077345, MLS001424194, GTPL4799, DTXSID8022828, BDBM38920, HMS2052K13, HMS2232C23, HMS3715F17, ACT02615, AMY22140, BCP02868, ZINC3798064, Tox21_110834, Tox21_300596, CC0168, NSC-05014, NSC-105014-F, AKOS015854898, AKOS015892544, AC-7591, BCP9000538, CCG-101116, CS-2057, DB00242, NC00366, NCGC00022567-05, NCGC00022567-06, NCGC00022567-07, NCGC00022567-08, NCGC00164384-01, NCGC00254518-01, 2-Chloro-2'-deoxyadenosine, antileukemic, AS-12366, BC164318, BP-25407, HY-13599

Pubchem:PUBCHEM:20279

Id:20279

Description:nan